Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion.
Nature communications
View this publicationNature communications
View this publicationJournal of clinical medicine
View this publicationFrontiers in immunology
View this publicationPloS one
View this publicationOsteoarthritis and cartilage
View this publicationSeminars in immunology
View this publicationJournal of imaging
View this publicationCirculation
View this publicationBMC cancer
View this publicationNature immunology
View this publication